B. Das et al., Genetic identity and differential expression of p38.5 (Haymaker) in human malignant and nonmalignant cells, INT J CANC, 94(6), 2001, pp. 800-806
Previous studies from our laboratory revealed a novel protein of 38.5 kD on
the surface of malignant cell lines of hematopoetic origin that exhibit su
sceptibility to naive natural killer (NK) cell-mediated lysis. In contrast,
p38.5 was not detected on the surface of NK cell-resistant carcinoma cell
lines or normal cells. We now report that this protein is differentially ex
pressed, intracellularly, in malignant cell lines of both hematopoetic and
epithelial origin compared with nonmalignant cells. To characterize p38.5 f
urther, we used a previously developed antipeptide antibody (anti-II-mer) t
o probe cDNA expression libraries and subsequently performed 5' extension b
y rapid amplification of cDNA ends (RACE). Sequence analyses of these cDNA
clones reveal open reading frames (ORFs) that include the previously identi
fied I I-mer peptide from purified, native p38.5 and that have identical se
quences to a gene of unknown function on chromosome 19. Nucleotide sequence
data obtained from these cDNA clones, as well as analysis of the genomic s
equence, permitted design of primers for reverse transcriptase-polymerase c
hain reaction (RT-PCR) that resulted in a cDNA clone encoding an ORF of 361
amino acids; the clone was identical to a sequence encoded by an unpublish
ed mRNA in GenBank. Anti-p38.5 antibody against the II-mer peptide encoded
in exon 5 and against a 25-mer peptide encoded in exon I both reacted with
the same protein in immunoprecipitation studies, providing further evidence
of identity. RT-PCR and Northern blot analyses both demonstrated p38.5 gen
e transcripts in normal cells, nonmalignant cell lines and malignant cell l
ines of epithelial as well as hematopoietic origin. Semiquantitative studie
s revealed a greater level of p38.5 gene transcription in malignant cell li
nes compared with nonmalignant cells. Immunoblot analyses of protein expres
sion confirmed and extended the latter studies by revealing substantially g
reater levels of the 38.5 kD protein in whole cell extracts of malignant ce
ll lines compared with nonmalignant cells. Quantitative differences in dete
ction of the 38.5 kD protein and mRNA in NK susceptible- hematopoietic mali
gnancies compared with NK resistant-carcinomas were not observed. These exp
eriments suggest that the p38.5 gene (Haymaker) is widely expressed in huma
n cells of different tissue origins but that elevated expression is associa
ted with the malignant phenotype. (C) 2001 Wiley-Liss, Inc.